XERIS BIOPHARMA HOLDINGS INC (XERS) Stock Earnings & Estimates
USA - NASDAQ:XERS - US98422E1038 - Common Stock
9.14 USD
-0.13 (-1.4%)
9 USD
-0.14 (-1.53%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 110.2M 122.18% | 163.914M 48.74% | 203.07M 23.89% | 292.2M 43.89% | 351.82M 20.40% | 409.39M 16.36% | 484.98M 18.46% | 580.53M 19.70% | 584.26M 0.64% | 533.05M -8.76% | 582.01M 9.18% | |
| EBITDA YoY % growth | -59.56M 43.07% | -30.85M 48.20% | -21.021M 31.86% | 48.654M 331.45% | 76.143M 56.50% | 95.88M 25.92% | 162.91M 69.91% | 184.86M 13.47% | 212.66M 15.04% | N/A | N/A | |
| EBIT YoY % growth | -71.8M 32.58% | -44.01M 38.70% | -33.646M 23.55% | 18.931M 156.27% | 51.265M 170.80% | 89.515M 74.61% | 158.43M 76.99% | 219.71M 38.68% | 220.52M 0.37% | N/A | N/A | |
| Operating Margin | -65.15% | -26.85% | -16.57% | 6.48% | 14.57% | 21.87% | 32.67% | 37.85% | 37.74% | N/A | N/A | |
| EPS YoY % growth | -0.70 53.95% | -0.45 35.71% | -0.38 15.56% | -0.03 93.29% | 0.24 1,052.00% | 0.37 52.94% | 0.65 75.82% | 0.94 43.75% | 1.13 20.65% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.00 103.71% | 0.04 227.50% | 0.04 173.66% | 0.06 712.00% | 0.06 1,483.25% | 0.10 157.79% |
| Revenue Q2Q % growth | 75.664M 39.43% | 82.049M 36.52% | 80.308M 33.58% | 86.972M 21.57% | 92.208M 21.87% | 97.648M 19.01% |
| EBITDA Q2Q % growth | 12.801M 476.39% | 18.156M 26.93% | 12.24M 22,994.34% | 10.506M -2.62% | 12.852M 0.40% | 14.688M -19.10% |
| EBIT Q2Q % growth | 6.834M 153.01% | 10.649M 534.25% | 8.16M 364.08% | 10.574M 135.92% | 11.866M 73.63% | 16.762M 57.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.01 90.00% | -0.03 | 0.02 | 64.35% |
| Q1 2025 Q2Q % growth | -0.06 57.14% | -0.05 | -0.01 | -10.30% |
| Q4 2024 Q2Q % growth | -0.03 70.00% | -0.06 | 0.03 | 53.56% |
| Q3 2024 Q2Q % growth | -0.11 -22.22% | -0.09 | -0.02 | -19.83% |
| Q2 2024 Q2Q % growth | -0.10 28.57% | -0.11 | 0.01 | 8.09% |
| Q1 2024 Q2Q % growth | -0.14 -16.67% | -0.12 | -0.02 | -17.64% |
| Q4 2023 Q2Q % growth | -0.10 | -0.10 | 0.00 | -0.04% |
| Q3 2023 Q2Q % growth | -0.09 43.75% | -0.12 | 0.03 | 23.94% |
| Q2 2023 Q2Q % growth | -0.14 26.32% | -0.13 | -0.01 | -7.65% |
| Q1 2023 Q2Q % growth | -0.12 52.00% | -0.17 | 0.05 | 29.76% |
| Q4 2022 Q2Q % growth | -0.10 76.19% | -0.16 | 0.06 | 37.75% |
| Q3 2022 Q2Q % growth | -0.16 58.97% | -0.17 | 0.01 | 4.93% |
| Q2 2022 Q2Q % growth | -0.19 53.66% | -0.23 | 0.04 | 19.01% |
| Q1 2022 Q2Q % growth | -0.25 16.67% | -0.26 | 0.01 | 3.50% |
| Q4 2021 Q2Q % growth | -0.42 -2.44% | -0.25 | -0.17 | -68.76% |
| Q3 2021 Q2Q % growth | -0.39 -11.43% | -0.38 | -0.01 | -3.34% |
| Q2 2021 Q2Q % growth | -0.41 34.92% | -0.31 | -0.10 | -33.99% |
| Q1 2021 Q2Q % growth | -0.30 66.29% | -0.35 | 0.05 | 14.13% |
| Q4 2020 Q2Q % growth | -0.41 66.67% | -0.39 | -0.02 | -5.23% |
| Q3 2020 Q2Q % growth | -0.35 71.31% | -0.53 | 0.18 | 33.76% |
| Q2 2020 Q2Q % growth | -0.63 50.78% | -0.75 | 0.12 | 15.62% |
| Q1 2020 Q2Q % growth | -0.89 16.82% | -0.91 | 0.02 | 1.74% |
| Q4 2019 Q2Q % growth | -1.23 | -1.16 | -0.07 | -6.34% |
| Q3 2019 Q2Q % growth | -1.22 | -1.25 | 0.03 | 2.56% |
| Q2 2019 Q2Q % growth | -1.28 | -0.96 | -0.32 | -33.50% |
| Q1 2019 Q2Q % growth | -1.07 | -0.78 | -0.29 | -38.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 71.539M 48.84% | 65.867M | 5.672M | 8.61% |
| Q1 2025 Q2Q % growth | 60.119M 47.94% | 58.762M | 1.357M | 2.31% |
| Q4 2024 Q2Q % growth | 60.099M 35.39% | 59.266M | 833K | 1.41% |
| Q3 2024 Q2Q % growth | 54.268M 12.31% | 52.462M | 1.806M | 3.44% |
| Q2 2024 Q2Q % growth | 48.065M 26.46% | 46.727M | 1.338M | 2.86% |
| Q1 2024 Q2Q % growth | 40.638M 22.42% | 42.651M | -2.013M | -4.72% |
| Q4 2023 Q2Q % growth | 44.39M 33.95% | 44.423M | -33K | -0.07% |
| Q3 2023 Q2Q % growth | 48.32M 62.53% | 41.905M | 6.415M | 15.31% |
| Q2 2023 Q2Q % growth | 38.008M 50.17% | 35.534M | 2.474M | 6.96% |
| Q1 2023 Q2Q % growth | 33.196M 50.41% | 31.381M | 1.815M | 5.78% |
| Q4 2022 Q2Q % growth | 33.14M 54.64% | 31.659M | 1.481M | 4.68% |
| Q3 2022 Q2Q % growth | 29.73M 168.81% | 29.705M | 25K | 0.08% |
| Q2 2022 Q2Q % growth | 25.31M 184.06% | 26.042M | -732K | -2.81% |
| Q1 2022 Q2Q % growth | 22.07M 169.15% | 24.059M | -1.989M | -8.27% |
| Q4 2021 Q2Q % growth | 21.43M 198.88% | 19.276M | 2.154M | 11.17% |
| Q3 2021 Q2Q % growth | 11.06M 17.04% | 11.247M | -187K | -1.66% |
| Q2 2021 Q2Q % growth | 8.91M 338.92% | 9.735M | -825K | -8.47% |
| Q1 2021 Q2Q % growth | 8.2M 358.10% | 7.617M | 583K | 7.65% |
| Q4 2020 Q2Q % growth | 7.17M 291.80% | 8.372M | -1.202M | -14.36% |
| Q3 2020 Q2Q % growth | 9.45M 2,948.39% | 4.568M | 4.882M | 106.87% |
| Q2 2020 Q2Q % growth | 2.03M 576.67% | 1.899M | 131K | 6.90% |
| Q1 2020 Q2Q % growth | 1.79M 616.00% | 1.457M | 333K | 22.86% |
| Q4 2019 Q2Q % growth | 1.83M | 670.548K | 1.159M | 172.91% |
| Q3 2019 Q2Q % growth | 310K | 51K | 259K | 507.84% |
| Q2 2019 Q2Q % growth | 300K | 51K | 249K | 488.24% |
| Q1 2019 Q2Q % growth | 250K | 102K | 148K | 145.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 180% | 62.5% | 47.37% |
| Revenue | 0% | 5.97% | 0% | 6.56% |